GO Report

Basic Info

ID	GO:0008144
Name	drug binding
Type	molecular function
No. of Genes in PTSDgene	13

GO related genes in PTSDgene (count: 13)

Approved Symbol	Approved Name	Location	Type	No. of Association Studies (Positive/Negative/Trend)	Evidence[PMID]
CHRNA2	cholinergic receptor, nicotinic alpha 2	8p21	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target	1(1/0/0)	IEA
SLC18A2	solute carrier family 18 (vesicular monoamine transporter), member 2	10q25	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	3(2/1/0)	IEA
IL2RA	interleukin 2 receptor subunit alpha	10p15-p14	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	1(1/0/0)	IEA
DRD4	dopamine receptor D4	11p15.5	Literature-origin, Mapped by Literature SNP	7(2/5/0)	IDA[1319557\|1840645\|8413587]
CHRNB4	cholinergic receptor, nicotinic beta 4	15q24	Mapped by Literature SNP, Mapped by LD-proxy, rSNP target	0	IEA
CNR1	cannabinoid receptor 1 (brain)	6q14-q15	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	2(0/2/0)	IEA
ADRB2	adrenoceptor beta 2	5q31-q32	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	1(0/1/0)	IEA
CHRNB3	cholinergic receptor, nicotinic beta 3	8p11.21	Mapped by Literature SNP, Mapped by LD-proxy	0	IEA
DRD3	dopamine receptor D3	3q13.3	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	2(1/1/0)	IDA[8413587]; ISS
CHRNA3	cholinergic receptor, nicotinic alpha 3	15q24	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target	1(0/1/0)	IEA
DRD2	dopamine receptor D2	11q23.2	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	18(11/7/0)	IDA[8413587]
SLC6A3	solute carrier family 6 (neurotransmitter transporter), member 3	5p15.3	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	21(11/10/0)	IEA
HTR2A	5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled	13q14-q21	Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy	4(2/2/0)	IDA[15831837\|15862800\|18703043]